Senior insider sale
EVP, Chf Clinical Develop Offc at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$3.88M
47.88K shares
What this filing means
SCHNEIDER EUGENE plans to sell 47.88K shares of IONIS PHARMACEUTICALS INC valued at approximately $3.88M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/26/2026ACC: 0001972481-26-000213
Officer· EVP, Chf Clinical Develop Offc
Since Dec 2020
47.88K
Shares to sell
$3.88M
Approx. market value
47.88K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Stock Option Exercise
Equity Compensation
1/4/2021
21.88KStock Option Exercise
Equity Compensation
1/2/2020
26KTotal acquired47.88K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/4/2021 | Stock Option Exercise Equity Compensation | 21.88K | — |
1/2/2020 | Stock Option Exercise Equity Compensation | 26K | — |
| Total | 47.88K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
47.88K
Market value
$3.88M
6/26/2026
Total
Units
47.88K
Value
$3.88M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/26/2026 | 47.88K | $3.88M | Nasdaq | Planned |
| Total | 47.88K | $3.88M | ||